Invectys Employee Directory
Biotechnology ResearchÎle-de-France, France11-50 Employees
Invectys is a privately held, clinical-stage biotechnology company developing cancer immunotherapies. It operates through two wholly owned subsidiaries—Invectys SAS in Paris focused on scientific research and Invectys USA, Inc. in Houston that leads the clinical development of its lead HLA-G product. The organization targets universal tumor antigens and aims to advance first-in-class therapies for solid tumors. Based in Houston with a Paris research arm, the company positions itself in the biotechnology research sector as a developer of next-generation cancer immunotherapies for patients. A recent development from 2025 includes participation in ASCO, where Invectys presented the first-in-human trial design for its HLA-G–targeted CAR T therapy.
1-888-653-2347 
support@leadiq.com 
